Purchase Order 75D30120P09087
- Not listed
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed price purchase order to Clarivate Analytics (Us) LLC, a foreign-owned for-profit organization, for a software subscription with a potential value of $201,477.04. The contract is for the provision of Clarivate's proprietary research databases, analytical tools, academic journals, and other scientific literature to support the agency's research, analysis, and program evaluation functions....
- This is a $195,886.92 firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Clarivate Analytics (Us) LLC, a foreign-owned for-profit organization, for an annual subscription to the Clarivate research database and analytics platforms. The contract has an ultimate completion date of September 12, 2028 and was awarded on September 13, 2023 without a set-aside designation. Clarivate Analytics provides scientific, technical, medical, and scholarly...
- This is a $89,238.28 firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Clarivate Analytics (Us) LLC for the renewal of the ScholarOne software platform. ScholarOne is a web-based manuscript submission and peer review system used by the CDC and other federal agencies to manage the publication of scientific and technical research. This contract does not have a set-aside designation. Clarivate is a global leader in providing...
- This is a federal contract award from the Centers for Disease Control and Prevention (CDC) to Clarivate Analytics (Us) LLC for software license renewal. The contract has a ceiling value of $125,592.00 and is a Firm Fixed Price Purchase Order. The award was made on January 1, 2017 with a completion date of January 19, 2020. The contract does not have a set-aside designation. Clarivate Analytics is a global provider of scientific, technical, and scholarly research tools, including proprietary...
- This is a definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Clarivate Analytics (Us) LLC, a global leader in scientific, technical, medical, and scholarly research analytics. The $291,080.00 firm-fixed-price contract is for the provision of laboratory supplies and has an ultimate completion date of July 29, 2020. Clarivate Analytics holds multiple federal contracts, including a $200 million single-award indefinite delivery contract through the Library of...
- This is a $141,558 firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Clarivate Analytics (Us) LLC. The contract is for the provision of the Thomson Reuters ScholarOne system, a proprietary software and database platform that supports scientific and scholarly publishing workflows. The award does not have a set-aside designation. Clarivate Analytics is a global leader in providing subscription-based scientific, technical, and medical research...
- The Centers for Disease Control and Prevention awarded a purchase order to Elsevier Inc. for Elsevier Journal Subscriptions with a ceiling value of $6,667,678.50 on January 1, 2023. The order runs through December 31, 2027 and covers approximately 300 journal titles via ScienceDirect, along with access to Compendex, Scopus, and Scopus Custom Data. This is a sole-source, firm fixed-price award with no set-aside. Work is performed in Atlanta, Georgia. The procurement originated from a CDC...
- <p>The CDC Pittsburgh awarded a purchase order to Clarivate Analytics (Us) LLC for a ScholarOne annual subscription valued at $419,224.46, with an award date of August 29, 2024 and ultimate completion date of July 29, 2026. Performance occurs in Atlanta, Georgia. The order is priced firm fixed and carries no set-aside designation.</p>
- The Centers for Disease Control and Prevention (CDC) Pittsburgh facility awarded a firm fixed-price purchase order to Clarivate Analytics (US) LLC for an EndNote Software License on June 1, 2022, with a ceiling value of $193,471.45 and completion date of November 30, 2025. This contract, which received no set-aside designation, provides the CDC with access to EndNote, a widely-used bibliographic management and citation tool that supports researchers in organizing references, managing...
- This federal contract award was made by the Centers for Disease Control and Prevention (CDC) to Elsevier B.V., a global information analytics company. The contract, valued at $132,019.00, is for the provision of Elsevier's ELSEVIER DIRECT SUBJECT BACKFILES, which provide access to scientific, technical, and medical content, including journals, books, and databases. The contract has no set-aside designation and is a firm-fixed-price purchase order. Elsevier B.V. is a major provider of online...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed price purchase order to Clarivate Analytics (Us) LLC, a foreign-owned for-profit organization, for an EID Scholarone Manuscripts and Subscription for NCEZID with a potential value of $225,254.00. The contract was awarded on a sole source basis under the authority of 10 U.S.C. 2304(c)(1) for a 12-month base period and 12-month option period. No set-aside designation was used. Clarivate Analytics provides scientific literature databases and analytics platforms to federal agencies, including the CDC, to support research, analysis, and program evaluation functions. This contract provides the CDC's National Center for Emerging and Zoonotic Infectious Diseases with access to Clarivate's manuscript submission and subscription services.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Emerging Infectious Diseases (EID) Manuscript License | 75D30120Q72131 | Department of Health and Human Services Centers for Disease Control and Prevention Office of Acquisition Services | Pre-Solicitation 1/1 | 7/9/20, 6:24 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Exercise an Option | $113.1k | 8/24/21 | |
| P00001 | Other Administrative Action | $0 | 7/23/20 | |
| Not listed | Not listed | $112.2k | 7/22/20 |